Published in Proc Natl Acad Sci U S A on March 04, 2009
An interaction between kynurenine and the aryl hydrocarbon receptor can generate regulatory T cells. J Immunol (2010) 3.75
Exposure to atmospheric particulate matter enhances Th17 polarization through the aryl hydrocarbon receptor. PLoS One (2013) 1.06
Sequence variants at CYP1A1-CYP1A2 and AHR associate with coffee consumption. Hum Mol Genet (2011) 1.03
Aryl hydrocarbon receptor nuclear translocator in hepatocytes is required for aryl hydrocarbon receptor-mediated adaptive and toxic responses in liver. Toxicol Sci (2010) 0.98
Genome-wide computational analysis of dioxin response element location and distribution in the human, mouse, and rat genomes. Chem Res Toxicol (2011) 0.96
The aryl hydrocarbon receptor-interacting protein (AIP) is required for dioxin-induced hepatotoxicity but not for the induction of the Cyp1a1 and Cyp1a2 genes. J Biol Chem (2010) 0.95
2,3,7,8-Tetrachlorodibenzo-p-dioxin treatment alters eicosanoid levels in several organs of the mouse in an aryl hydrocarbon receptor-dependent fashion. Toxicol Appl Pharmacol (2011) 0.92
Inherited liver shunts in dogs elucidate pathways regulating embryonic development and clinical disorders of the portal vein. Mamm Genome (2011) 0.90
Indole and Tryptophan Metabolism: Endogenous and Dietary Routes to Ah Receptor Activation. Drug Metab Dispos (2015) 0.83
Augmented oxygen-mediated transcriptional activation of cytochrome P450 (CYP)1A expression and increased susceptibilities to hyperoxic lung injury in transgenic mice carrying the human CYP1A1 or mouse 1A2 promoter in vivo. Biochem Biophys Res Commun (2011) 0.82
AhR-mediated effects of dioxin on neuronal acetylcholinesterase expression in vitro. Environ Health Perspect (2013) 0.82
Disruption of the gene for CYP1A2, which is expressed primarily in liver, leads to differential regulation of hepatic and pulmonary mouse CYP1A1 expression and augmented human CYP1A1 transcriptional activation in response to 3-methylcholanthrene in vivo. J Pharmacol Exp Ther (2010) 0.81
Persistent induction of cytochrome P450 (CYP)1A enzymes by 3-methylcholanthrene in vivo in mice is mediated by sustained transcriptional activation of the corresponding promoters. Biochem Biophys Res Commun (2009) 0.81
Altered subcellular localization of heat shock protein 90 is associated with impaired expression of the aryl hydrocarbon receptor pathway in dogs. PLoS One (2013) 0.81
Aryl hydrocarbon receptor ligand 2,3,7,8-tetrachlorodibenzo-p-dioxin enhances liver damage in bile duct-ligated mice. Toxicology (2010) 0.81
Liver tumor promotion by 2,3,7,8-tetrachlorodibenzo-p-dioxin is dependent on the aryl hydrocarbon receptor and TNF/IL-1 receptors. Toxicol Sci (2014) 0.80
New CYP1 genes in the frog Xenopus (Silurana) tropicalis: induction patterns and effects of AHR agonists during development. Toxicol Appl Pharmacol (2010) 0.80
Persistent induction of cytochrome P4501A1 in human hepatoma cells by 3-methylcholanthrene: evidence for sustained transcriptional activation of the CYP1A1 promoter. J Pharmacol Exp Ther (2010) 0.80
Aryl hydrocarbon receptor-dependent apoptotic cell death induced by the flavonoid chrysin in human colorectal cancer cells. Cancer Lett (2015) 0.78
Juvenile Male Rats Exposed to a Low-Dose Mixture of Twenty-Seven Environmental Chemicals Display Adverse Health Effects. PLoS One (2016) 0.75
Dichotomous effects of aryl hydrocarbon receptor (AHR) activation on human fetoplacental endothelial cell function. Placenta (2016) 0.75
The aryl hydrocarbon receptor repressor - More than a simple feedback inhibitor of AhR signaling: Clues for its role in inflammation and cancer. Curr Opin Toxicol (2017) 0.75
A cre-transgenic mouse strain for the ubiquitous deletion of loxP-flanked gene segments including deletion in germ cells. Nucleic Acids Res (1995) 12.21
Widespread recombinase expression using FLPeR (flipper) mice. Genesis (2001) 7.08
P450 genes: structure, evolution, and regulation. Annu Rev Biochem (1987) 6.72
The aryl hydrocarbon receptor complex. Annu Rev Pharmacol Toxicol (1995) 6.37
P450 superfamily: update on new sequences, gene mapping, accession numbers and nomenclature. Pharmacogenetics (1996) 6.12
The PAS superfamily: sensors of environmental and developmental signals. Annu Rev Pharmacol Toxicol (2000) 4.79
Characterization of a murine Ahr null allele: involvement of the Ah receptor in hepatic growth and development. Proc Natl Acad Sci U S A (1996) 4.66
Induction of cytochrome P4501A1. Annu Rev Pharmacol Toxicol (1999) 3.94
The role of the loxP spacer region in P1 site-specific recombination. Nucleic Acids Res (1986) 3.63
Flp recombinase promotes site-specific DNA recombination in embryonic stem cells and transgenic mice. Proc Natl Acad Sci U S A (1996) 3.21
Portosystemic shunting and persistent fetal vascular structures in aryl hydrocarbon receptor-deficient mice. Proc Natl Acad Sci U S A (2000) 2.22
Aryl hydrocarbon receptor-dependent liver development and hepatotoxicity are mediated by different cell types. Proc Natl Acad Sci U S A (2005) 1.82
The molecular genetics of bacteriophage P1. Annu Rev Genet (1983) 1.75
Resistance to 2,3,7,8-tetrachlorodibenzo-p-dioxin toxicity and abnormal liver development in mice carrying a mutation in the nuclear localization sequence of the aryl hydrocarbon receptor. J Biol Chem (2003) 1.64
Patent ductus venosus and dioxin resistance in mice harboring a hypomorphic Arnt allele. J Biol Chem (2004) 1.56
Short-term toxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin in laboratory animals: effects, mechanisms, and animal models. Pharmacol Rev (1994) 1.55
Comparative analysis of dioxin response elements in human, mouse and rat genomic sequences. Nucleic Acids Res (2004) 1.52
EDGE: a centralized resource for the comparison, analysis, and distribution of toxicogenomic information. Mol Pharmacol (2005) 1.43
Abnormal liver development and resistance to 2,3,7,8-tetrachlorodibenzo-p-dioxin toxicity in mice carrying a mutation in the DNA-binding domain of the aryl hydrocarbon receptor. Toxicol Sci (2008) 1.38
Cyp1a2(-/-) null mutant mice develop normally but show deficient drug metabolism. Proc Natl Acad Sci U S A (1996) 1.35
Regulation of CYP1A1 expression. FASEB J (1992) 1.31
CYP1A induction and human risk assessment: an evolving tale of in vitro and in vivo studies. Drug Metab Dispos (2007) 1.30
Gestational exposure of Ahr and Arnt hypomorphs to dioxin rescues vascular development. Proc Natl Acad Sci U S A (2004) 1.27
Aspects of dioxin toxicity are mediated by interleukin 1-like cytokines. Mol Pharmacol (2005) 1.24
TCDD-induced changes in rat liver microsomal enzymes. Environ Health Perspect (1973) 1.24
Targeted knockout of Cyp1a1 gene does not alter hepatic constitutive expression of other genes in the mouse [Ah] battery. Biochem Biophys Res Commun (2000) 1.24
Cyp1a1(-/-) male mice: protection against high-dose TCDD-induced lethality and wasting syndrome, and resistance to intrahepatocyte lipid accumulation and uroporphyria. Toxicol Appl Pharmacol (2004) 1.23
The human CYP1A2 gene and induction by 3-methylcholanthrene. A region of DNA that supports AH-receptor binding and promoter-specific induction. J Biol Chem (1994) 1.16
Organization of the CYP1A cluster on human chromosome 15: implications for gene regulation. Pharmacogenetics (2001) 1.11
Sequence variation and phylogenetic history of the mouse Ahr gene. Pharmacogenetics (2002) 1.11
Liver deformation in Ahr-null mice: evidence for aberrant hepatic perfusion in early development. Mol Pharmacol (2006) 1.09
Induction of drug-metabolizing enzymes by dioxin. Drug Metab Rev (1997) 1.09
Functional analysis of the transcriptional promoter for the CYP1A1 gene. Mol Cell Biol (1990) 1.07
A common regulatory region functions bidirectionally in transcriptional activation of the human CYP1A1 and CYP1A2 genes. Mol Pharmacol (2006) 1.06
Deletion of the aryl hydrocarbon receptor-associated protein 9 leads to cardiac malformation and embryonic lethality. J Biol Chem (2007) 1.03
Functional analysis of the human cytochrome P4501A1 (CYP1A1) gene enhancer. Eur J Biochem (1998) 0.99
Stereoselectivity of cytochrome P-450 isozymes and epoxide hydrolase in the metabolism of polycyclic aromatic hydrocarbons. Biochem Pharmacol (1988) 0.96
Protection of the Cyp1a2(-/-) null mouse against uroporphyria and hepatic injury following exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin. Toxicol Appl Pharmacol (2001) 0.94
A hypomorphic allele of aryl hydrocarbon receptor-associated protein-9 produces a phenocopy of the AHR-null mouse. Mol Pharmacol (2008) 0.94
Hepatic transcriptional networks induced by exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin. Chem Res Toxicol (2007) 0.93
Isolation and characterization of a dioxin-inducible CYP1A1 promoter/enhancer region from zebrafish (Danio rerio). Zebrafish (2005) 0.92
Conserved genomic structure of the Cyp1a1 and Cyp1a2 loci and their dioxin responsive elements cluster. Biochem Pharmacol (2008) 0.87
Carcinogenic risks of dioxin: mechanistic considerations. Regul Toxicol Pharmacol (2005) 0.85
Methoxyresorufin: an inappropriate substrate for CYP1A2 in the mouse. Biochem Pharmacol (1998) 0.85
Characterization of the rabbit CYP1A1 and CYP1A2 genes: developmental and dioxin-inducible expression of rabbit liver P4501A1 and P4501A2. Arch Biochem Biophys (1992) 0.83
Ultrastructural changes in rat liver cells following a single oral dose of TCDD. Environ Health Perspect (1973) 0.82
2,3,7,8-Tetrachlorodibenzo-p-dioxin mechanistic data and risk assessment: gene regulation, cytotoxicity, enhanced cell proliferation, and tumor promotion. Pharmacol Ther (1996) 0.81
Expression of the chloramphenicol acetyltransferase (CAT) reporter gene by the murine Cyp1a-2 (cytochrome P3(450)) promoter in hepatoma cell cultures. Biochem Biophys Res Commun (1990) 0.80
The use of biochemical and molecular parameters to estimate dose-response relationships at low levels of exposure. Environ Health Perspect (1998) 0.77
Alemtuzumab vs. interferon beta-1a in early multiple sclerosis. N Engl J Med (2008) 6.86
Disruption of the clock components CLOCK and BMAL1 leads to hypoinsulinaemia and diabetes. Nature (2010) 5.97
An interaction between kynurenine and the aryl hydrocarbon receptor can generate regulatory T cells. J Immunol (2010) 3.75
The search for endogenous activators of the aryl hydrocarbon receptor. Chem Res Toxicol (2007) 3.68
AHR drives the development of gut ILC22 cells and postnatal lymphoid tissues via pathways dependent on and independent of Notch. Nat Immunol (2011) 2.99
Dissecting the functions of the mammalian clock protein BMAL1 by tissue-specific rescue in mice. Science (2006) 2.41
The aryl hydrocarbon receptor: a perspective on potential roles in the immune system. Immunology (2009) 2.31
Progressive arthropathy in mice with a targeted disruption of the Mop3/Bmal-1 locus. Genesis (2005) 2.30
Alemtuzumab versus interferon β-1a in early relapsing-remitting multiple sclerosis: post-hoc and subset analyses of clinical efficacy outcomes. Lancet Neurol (2011) 2.26
Inactivation of the arylhydrocarbon receptor nuclear translocator (Arnt) suppresses von Hippel-Lindau disease-associated vascular tumors in mice. Mol Cell Biol (2005) 2.25
Obesity in mice with adipocyte-specific deletion of clock component Arntl. Nat Med (2012) 2.13
Mammalian Per-Arnt-Sim proteins in environmental adaptation. Annu Rev Physiol (2010) 1.94
Aryl hydrocarbon receptor-dependent liver development and hepatotoxicity are mediated by different cell types. Proc Natl Acad Sci U S A (2005) 1.82
The aryl hydrocarbon receptor sans xenobiotics: endogenous function in genetic model systems. Mol Pharmacol (2007) 1.77
Resistance to 2,3,7,8-tetrachlorodibenzo-p-dioxin toxicity and abnormal liver development in mice carrying a mutation in the nuclear localization sequence of the aryl hydrocarbon receptor. J Biol Chem (2003) 1.64
Genetic components of the circadian clock regulate thrombogenesis in vivo. Circulation (2008) 1.62
Patent ductus venosus and dioxin resistance in mice harboring a hypomorphic Arnt allele. J Biol Chem (2004) 1.56
The aryl hydrocarbon receptor is required for developmental closure of the ductus venosus in the neonatal mouse. Mol Pharmacol (2004) 1.56
EDGE: a centralized resource for the comparison, analysis, and distribution of toxicogenomic information. Mol Pharmacol (2005) 1.43
Abnormal liver development and resistance to 2,3,7,8-tetrachlorodibenzo-p-dioxin toxicity in mice carrying a mutation in the DNA-binding domain of the aryl hydrocarbon receptor. Toxicol Sci (2008) 1.38
Gestational exposure of Ahr and Arnt hypomorphs to dioxin rescues vascular development. Proc Natl Acad Sci U S A (2004) 1.27
Aspects of dioxin toxicity are mediated by interleukin 1-like cytokines. Mol Pharmacol (2005) 1.24
The aryl hydrocarbon receptor is activated by modified low-density lipoprotein. Proc Natl Acad Sci U S A (2007) 1.20
Sequence variation and phylogenetic history of the mouse Ahr gene. Pharmacogenetics (2002) 1.11
Liver deformation in Ahr-null mice: evidence for aberrant hepatic perfusion in early development. Mol Pharmacol (2006) 1.09
Reduced nitric oxide causes age-associated impairment of circadian rhythmicity. Circ Res (2008) 1.06
Similarity queries for temporal toxicogenomic expression profiles. PLoS Comput Biol (2008) 1.06
Deletion of the aryl hydrocarbon receptor-associated protein 9 leads to cardiac malformation and embryonic lethality. J Biol Chem (2007) 1.03
EDGE(3): a web-based solution for management and analysis of Agilent two color microarray experiments. BMC Bioinformatics (2009) 1.01
D-amino acid oxidase generates agonists of the aryl hydrocarbon receptor from D-tryptophan. Chem Res Toxicol (2009) 1.01
Polycyclic aromatic hydrocarbons as skin carcinogens: comparison of benzo[a]pyrene, dibenzo[def,p]chrysene and three environmental mixtures in the FVB/N mouse. Toxicol Appl Pharmacol (2012) 0.98
Aryl hydrocarbon receptor nuclear translocator in hepatocytes is required for aryl hydrocarbon receptor-mediated adaptive and toxic responses in liver. Toxicol Sci (2010) 0.98
Aspartate aminotransferase generates proagonists of the aryl hydrocarbon receptor. Mol Pharmacol (2003) 0.98
A maternal Ahr null genotype sensitizes embryos to chemical teratogenesis. J Biol Chem (2004) 0.95
The aryl hydrocarbon receptor-interacting protein (AIP) is required for dioxin-induced hepatotoxicity but not for the induction of the Cyp1a1 and Cyp1a2 genes. J Biol Chem (2010) 0.95
Aryl hydrocarbon receptor response to indigoids in vitro and in vivo. Arch Biochem Biophys (2004) 0.94
A hypomorphic allele of aryl hydrocarbon receptor-associated protein-9 produces a phenocopy of the AHR-null mouse. Mol Pharmacol (2008) 0.94
Transforming growth factor-beta3 restores fusion in palatal shelves exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin. J Biol Chem (2005) 0.93
Hepatic transcriptional networks induced by exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin. Chem Res Toxicol (2007) 0.93
Application of genomics to toxicology research. Environ Health Perspect (2002) 0.89
Identification of the Ah-receptor structural determinants for ligand preferences. Toxicol Sci (2012) 0.89
SU5416, a VEGF receptor inhibitor and ligand of the AHR, represents a new alternative for immunomodulation. PLoS One (2012) 0.89
Conserved genomic structure of the Cyp1a1 and Cyp1a2 loci and their dioxin responsive elements cluster. Biochem Pharmacol (2008) 0.87
Structural identification of Diindole agonists of the aryl hydrocarbon receptor derived from degradation of indole-3-pyruvic acid. Chem Res Toxicol (2009) 0.87
Interaction networks in yeast define and enumerate the signaling steps of the vertebrate aryl hydrocarbon receptor. PLoS Biol (2004) 0.87
Differential action of monohydroxylated polycyclic aromatic hydrocarbons with estrogen receptors α and β. Toxicol Sci (2012) 0.87
2,3,7,8-Tetrachlorodibenzo-p-dioxin induces premature activation of the KLF2 regulon during thymocyte development. J Biol Chem (2007) 0.86
Immunology: T cells hang in the balance. Nature (2008) 0.83
The Aryl Hydrocarbon Receptor Influences Transplant Outcomes in Response to Environmental Signals. Toxicol Environ Chem (2012) 0.81
Advances in toxicogenomics. Chem Res Toxicol (2005) 0.80
The PPCD1 mouse: characterization of a mouse model for posterior polymorphous corneal dystrophy and identification of a candidate gene. PLoS One (2010) 0.79
The aryl hydrocarbon receptor signaling pathway is modified through interactions with a Kelch protein. Mol Pharmacol (2006) 0.79
Developing toxicologically predictive gene sets using cDNA microarrays and Bayesian classification. Methods Enzymol (2002) 0.79
The teratogenic sensitivity to 2,3,7,8-tetrachlorodibenzo-p-dioxin is modified by a locus on mouse chromosome 3. Mol Pharmacol (2005) 0.79
Phase 1/2 study of orteronel (TAK-700), an investigational 17,20-lyase inhibitor, with docetaxel-prednisone in metastatic castration-resistant prostate cancer. Invest New Drugs (2015) 0.79
Clustered alignments of gene-expression time series data. Bioinformatics (2009) 0.78
A time to divide: does the circadian clock control cell cycle? Dev Cell (2006) 0.78
Interdisciplinary teamwork and the power of a quality improvement collaborative in tertiary neonatal intensive care units. J Perinat Neonatal Nurs (2015) 0.77
The Aryl Hydrocarbon Receptor is a Repressor of Inflammation-associated Colorectal Tumorigenesis in Mouse. Ann Surg (2016) 0.76
Sustaining SLUG Bug CLABSI Reduction: Does Sterile Tubing Change Technique Really Work? Pediatrics (2017) 0.75